Protective actions of green tea polyphenols and alfacalcidol on bone microstructure in female rats with chronic inflammation

Journal of Nutritional Biochemistry

Volumn 22, Issue 7, 2011, Pages 673-680

  Shen, Chwan Li ^a,b   Yeh, James K ^c   Samathanam, Christina ^a   Cao, Jay J ^d   Stoecker, Barbara J ^e   Dagda, Raul Y ^a   Chyu, Ming Chien ^a,f,g   Wang, Jia Sheng ^h  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c WINTHROP UNIVERSITY HOSPITAL   (United States)

^d GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

^e OKLAHOMA STATE UNIVERSITY   (United States)

^f Department of Electrical and Computer Engineering   (United States)

^g TEXAS TECH UNIVERSITY   (United States)

^h UNIVERSITY OF GEORGIA   (United States)

Author keywords

Alfacalcidol; Bone quality; Dietary supplement; Histomorphometry; Inflammation; Micro CT; Tea

Indexed keywords

ALFACALCIDOL; LIPOPOLYSACCHARIDE; PLACEBO; POLYPHENOL DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE MASS; BONE STRENGTH; BONE STRUCTURE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORTICAL BONE; DRUG ACTIVITY; DRUG EFFECT; FEMALE; FEMUR; NONHUMAN; OSSIFICATION; OSTEOCLAST; PERIOSTEUM; PROTECTION; PROTEIN EXPRESSION; RAT; TEA; TIBIA; TIBIA SHAFT; TRABECULAR BONE;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; FEMALE; FEMUR; FLAVONOIDS; HYDROXYCHOLECALCIFEROLS; INFLAMMATION; PHENOLS; RATS; TEA; TIBIA; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 79958813738     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.05.007     Document Type: Article

References (46)

1. Smith B.J., Lerner M.R., Bu S.Y., Lucas E.A., Hanas J.S., Lightfoot S.A., et al. Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation. Bone 2006, 38(3):378-386.
2. Shen C.L., Yeh J.K., Cao J.J., Tatum O.L., Dagda R.Y., Wang J.S. Green tea polyphenols mitigate bone loss of female rats in a chronic inflammation-induced bone loss model. J Nutr Biochem 2010, 21:968-974.
3. Dumitrescu A.L., Abd-El-Aleem S., Morales-Aza B., Donaldson L.F. A model of periodontitis in the rat: effect of lipopolysaccharide on bone resorption, osteoclast activity, and local peptidergic innervation. J Clin Periodontol 2004, 31(8):596-603.
4. Romas E., Gillespie M.T., Martin T.J. Involvement of receptor activator of NF-κB ligand and tumor cecrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 2003, 30:340-346.
5. Miyaura C., Inada M., Matsumoto C., Ohshiba T., Uozumi N., Shimizu T., et al. An essential role of cytosolic phospholipase A2alpha in prostaglandin E2-mediated bone resorption associated with inflammation. J Exp Med 2003, 197(10):1303-1310.
6. Cochran D.L. Inflammation and bone loss in periodontal disease. J Periodontol 2008, 79(8 Suppl):1569-1576.
7. Banfi G., Iorio E.L., Corsi M.M. Oxidative stress, free radicals and bone remodeling. Clin Chem Lab Med 2008, 46(11):1550-1555. [Review].
8. Shen C.L., Yeh J.K., Stoecker B.J., Chyu M.C., Wang J.S. Green tea polyphenols mitigate deterioration of bone microarchitecture in middle-aged female rats. Bone 2009, 44(4):684-690.
9. Scharla S.H., Schacht E., Lempert U.G. Alfacalcidol versus plain vitamina D in inflammation induced bone loss. J Rheumatol Suppl 2005, 76:26-32.
10. Droke E.A., Hager K.A., Lerner M.R., Lightfoot S.A., Stoecker B.J., Brackett D.J., et al. Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease. J Inflamm (Lond) 2007, 4:17.
11. Bu S.Y., Lerner M., Stoecker B.J., Boldrin E., Brackett D.J., Lucas E.A., et al. Dried plum polyphenols inhibit osteoclastogenesis by downregulating NFATc1 and inflammatory mediators. Calcif Tissue Int 2008, 82(6):475-488.
12. Shen C.L., Yeh J.K., Cao J., Wang J.S. Green tea and bone metabolism. Nutr Res 2009, 29(7):437-456. [Review].
13. Das M., Sur P., Gomes A., Vedasiromoni J.R., Ganguly D.K. Inhibition of tumor growth and inflammation by consumption of tea. Phytother Res Suppl 2002, 1:S40-S44.
14. Varilek G.W., Yang F., Lee E.Y., deVilliers W.J., Zhong J., Oz H.S., et al. Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. J Nutr 2001, 131(7):2034-2039.
15. Haqqi T.M., Anthony D.D., Gupta S., Ahmad N., Lee M.S., Kumar G.K., et al. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci U S A 1999, 96(8):4524-4529.
16. Nakamura H., Ukai T., Yoshimura A., Kozuka Y., Yoshioka H., Yoshinaga Y., et al. Green tea catechin inhibits lipopolysaccharide-induced bone resorption in vivo. J Periodontal Res 2009, [Epub ahead of print].
17. Iwamoto J., Seki A., Takeda T., Yamada H., Sato Y., Yeh J.K. Effects of alfacalcidol on cancellous and cortical bone mass in rats treated with glucocorticoid: a bone histomorphometry study. J Nutr Sci Vitaminol (Tokyo) 2007, 53(3):191-197.
18. Ringe J.D., Faber H., Fahramand P. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis. J Rheumatol Suppl 2005, 76:33-40.
19. Richy F., Deroisy R., Lecart M.P., Hanssens L., Mawet A., Reginster J.Y. D-hormone analog alfacalcifol: an update on its role in post-menopausal osteoporosis and rheumatoid arthritis management. Aging Clin Exp Res 2005, 17(2):133-142.
20. Iwamoto J., Takeda T., Matsumoto H., Sato Y., K Yeh J. Beneficial effects of combined administration of alendronate and alfacalcidol on cancellous bone mass of the tibia in orchidectomized rats: a bone histomorphometry study. J Nutr Sci Vitaminol 2008, 54(1):11-17.
21. Wang J.S., Luo H., Wang P., Tang L., Yu J., Huang T., et al. Validation of green tea polyphenol biomarkers in a phase II human intervention trial. Food Chem Toxicol 2008, 46(1):232-240.
22. Shen C.L., Wang P., Guerrieri J., Yeh J.K., Wang J.S. Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int 2008, 19(7):979-990.
23. Villanueva A.R., Mehr L.A. Modifications of the Goldner and Gomori one-step trichrome stains for plastic-embedded thin sections of bone. Am J Medica Tech 1977, 43:536-538.
24. Parfitt A.M., Drezner M.J., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J. Bone histomorphometry: Standardization of nomenclature, symbols and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
25. Nielsen F.H. Dietary fat composition modifies the effect of boron on bone characteristics and plasma lipids in rats. BioFactors 2004, 20:161-171.
26. Crenshaw T.D., Peo E.R., Lewis A.J., Moser B.D. Bone strength as a trait for assessing mineralization in swine: a critical review of techniques involved. J Anim Sci 1981, 53:827-835.
27. Nelson-Dooley C., Della-Fera M.A., Hamrick M., Baile C.A. Novel treatments for obesity and osteoporosis: targeting apoptotic pathways in adipocytes. Curr Med Chem 2005, 12(19):2214-2225.
28. Mount J.G., Muzylak M., Allen S., Althnaian T., McGonnell I.M., Price J.S. Evidence that the canonical Wnt signalling pathway regulates deer antler regeneration. Dev Dyn 2006, 235(5):1390-1399.
29. Tokuda H., Takai S., Matsushima-Nishiwaki R., Akamatsu S., Hanai Y., Hosoi T., et al. (-)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts. J Cell Biochem 2007, 100(5):1146-1153.
30. Vali B., Rao L.G., El-Sohemy A. (2007) Epigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cells. J Nutr Biochem 2007, 18(5):341-347.
31. Yun J.H., Kim C.S., Cho K.S., Chai J.K., Kim C.K., Choi S.H. (-)-Epigallocatechin gallate induces apoptosis, via caspase activation, in osteoclasts differentiated from RAW 264.7 cells. J Periodontal Res 2007, 42(3):212-218.
32. Nakagawa H., Wachi M., Woo J.T., Kato M., Kasai S., Takahashi F., et al. Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem Biophys Res Commun 2002, 292(1):94-101.
33. Yun J.H., Pang E.K., Kim C.S., Yoo Y.J., Cho K.S., Chai J.K., et al. Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts. J Periodontal Res 2004, 39(5):300-307.
34. Lee J.H., Jin H., Shim H.E., Kim H.N., Ha H., Lee Z.H. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the NF-{kappa}B signal. Mol Pharmacol 2009, [Epub ahead of print].
35. Jeong Y.I., Jung I.D., Lee J.S., Lee C.M., Lee J.D., Park Y.M. (-)-Epigallocatechin gallate suppresses indoleamine 2,3-dioxygenase expression in murine dendritic cells: evidences for the COX-2 and STAT1 as potential targets. Biochem Biophys Res Commun 2007, 354(4):1004-1009.
36. Mundy G.R. Cytokine and growth factors in the regulation of bone remodeling. J Bone Miner Res 2003, 8(Suppl 2):S505-S510.
37. Weber K., Kaschig C., Erben R.G. 1 Alpha-hydroxyvitamin D2 and 1 alpha hydroxyvitamin D3 have anabolic effects on cortical bone, but induce intracortical remodeling at toxic doses in ovariectomized rats. Bone 2004, 35(3):704-710.
38. Shibata T., Shira-Ishi A., Sato T., Masaki T., Masuda A., Hishiya A., et al. Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast recursors in bone marrow. J Bone Miner Res 2002, 17(4):622-629.
39. Ringe J.D., Schacht E. Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcido. Rheumatol Int 2004, 24(40):189-197.
40. Shiraishi A., Higashi S., Ohkawa H., Kubodera N., Hirasawa T., Ezawa I., et al. The advantage of alfacalcidol over vitamin D in the treatment of osteoporosis. Calcif Tissue Int 1999, 65(4):311-316.
41. Shiraki M., Fukuchi M., Kiriyama T., Okamoto S., Ueno T., Sakamoto H., et al. Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis. J Bone Miner Metab 2004, 22(4):352-359.
42. Silvestris F., Cafforio P., Calvani N., Dammacco F. Impaired osteoblastogenesis in myeloma bone disease: role of upregulated apoptosis by cytokines and malignant plasma cells. Br J Haematol 2004, 126(4):475-486.
43. Armour K.J., Armour K.E., van't Hof R.J., Reid D.M., Wei X.Q., Liew F.Y., et al. Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum 2001, 44(12):2790-2796.
44. Balga R., Wetterwald A., Portenier J., Dolder S., Mueller C., Hofstetter W. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro. Bone 2006, 39(2):325-335.
45. Robinson L.J., Borysenko C.W., Blair H.C. Tumor necrosis factor family receptors regulating bone turnover: new observations in osteoblastic and osteoclastic cell lines. Ann N Y Acad Sci 2007, 1116:432-443.
46. Cao H., Kelly M.A., Kari F., Dawson H.D., Urban J.F., Coves S., et al. Green tea increases anti-inflammatory tristetraprolin and decreases pro-inflammatory tumor necrosis factor mRNA levels in rats. J Inflamm (Lond) 2007, 4:1.